1. Severe COVID-19 infection. <br/ >2. History of Chronic Exposure to Smoking <br/ >3. other concurrent infections requiring systemic antiviral therapy prior to screening. <br/ >4. Administration of immunomodulators, interferon inducers, homeopathic, hormonal other than hormone replacement therapy, and antiviral drugs during the previous 4 weeks before the first dose. Use of corticosteroids as part of the current standard of care is permitted. <br/ >6. Allergy or known allergy to components of study medication (Peanuts and Mushroom). <br/ >7. Subjects with severe symptoms such as respiratory rate > 30 breaths per minute or saturation of oxygen (SpO2) < 90% on room air.

1. Severe COVID-19 infection. <br/ >2. History of Chronic Exposure to Smoking <br/ >3. other concurrent infections requiring systemic antiviral therapy prior to screening. <br/ >4. Administration of immunomodulators, interferon inducers, homeopathic, hormonal other than hormone replacement therapy, and antiviral drugs during the previous 4 weeks before the first dose. Use of corticosteroids as part of the current standard of care is permitted. <br/ >6. Allergy or known allergy to components of study medication (Peanuts and Mushroom). <br/ >7. Subjects with severe symptoms such as respiratory rate > 30 breaths per minute or saturation of oxygen (SpO2) < 90% on room air.

N/A

N/A

1. Severe COVID-19 infection. <br/ >2. History of Chronic Exposure to Smoking <br/ >3. other concurrent infections requiring systemic antiviral therapy prior to screening. <br/ >4. Administration of immunomodulators, interferon inducers, homeopathic, hormonal other than hormone replacement therapy, and antiviral drugs during the previous 4 weeks before the first dose. Use of corticosteroids as part of the current standard of care is permitted. <br/ >6. Allergy or known allergy to components of study medication (Peanuts and Mushroom). <br/ >7. Subjects with severe symptoms such as respiratory rate > 30 breaths per minute or saturation of oxygen (SpO2) < 90% on room air.

1. Severe COVID-19 infection. <br/ >2. History of Chronic Exposure to Smoking <br/ >3. other concurrent infections requiring systemic antiviral therapy prior to screening. <br/ >4. Administration of immunomodulators, interferon inducers, homeopathic, hormonal other than hormone replacement therapy, and antiviral drugs during the previous 4 weeks before the first dose. Use of corticosteroids as part of the current standard of care is permitted. <br/ >6. Allergy or known allergy to components of study medication (Peanuts and Mushroom). <br/ >7. Subjects with severe symptoms such as respiratory rate > 30 breaths per minute or saturation of oxygen (SpO2) < 90% on room air.